The essence of Graviton is that we are comprised of thought leaders who identify, research, and demonstrate the therapeutic potential of novel molecular and cellular pathways pathways.
Our team consists of eminent medicinal chemistry and clinical talent with deep-rooted biotech and pharma experience as well as leading executives and management who built the field of molecular and cellular pathways.
We not only transform laboratory discoveries into clinical research, we are committed to improving patient outcomes. With our platform’s origins in small molecule-based TDI01 pathway modulation (See Our Science), we develop therapeutics to penetrate the central nervous system and address a range of degenerative diseases, including certain cancers, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis other autoimmune diseases and other fibrotic disease.
Our Strategy
COMMITMENT
Founded in New York in 2020, the cornerstone of Graviton is innovative thought leadership to pave the way forward to discover and develop a diverse set of drug candidates. Our unified goal is the confluence of talent and vision so that as a company, we can achieve significant clinical impact. Our integrated approach begins with discovery in our labs, continues into clinical studies, extends into commercialization and ultimately transforms the lives of patients living with certain diseases. While we are dedicated to early-stage discovery and research capabilities as reflected in our our patent portfolio, our ultimate commitment is to satisfy unmet medical needs.
TRANSPARENCY
From our medical and scientific standards to our commitment to investors, Graviton was founded on the premise that all aspects of our business are transparent so we can optimize output. Graviton fosters collaboration, incorporates corporate governance, and applies our vision to target novel molecular and cellular pathways to achieve the utmost integrity for patients.
UNCONVENTIONAL
Our thought leadership is bold in that our founders pioneered the field of identifying and researching molecular and cellular pathways. We are fearless in our pursuit to connect our forward thinking ideas to bring about medical solutions.
Our Values
Integrity: We are committed to practicing business and scientific ethics to fairly and honestly achieve success. We are proud of our goals and the manner in which we achieve them.
Innovation: We look beyond the undiscovered. By connecting science and medicine, we bring value to patients.
Commitment to Excellence: We demand the most from ourselves and our partners.
Respect: At the core of what we do, we demonstrate respect for human life.
